Open Label Extension to Assess Long Term Safety and Efficacy of KL1333 in Patients With Primary Mitochondrial Disease
Clinical trial NCT07514338 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07514338
- Sponsor
- Pharming Technologies B.V.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-09
- Primary completion
- 2029-03-31
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.